“Effectiveness and tolerability of early initiation of combined lipid-lowering therapy included simvastatin and fenofibrate vs simvastatin alone in patients with acute coronary syndrome and type 2 diabetes mellitus with hypertriglyceridemia” (2020) Ukrainian Journal of Cardiology, 27(2), pp. 34–45. doi:10.31928/1608-635X-2020.2.3445.